Abstract
Purpose
Preclinical studies of hypoxia are generally done using ectopic xenograft tumors, which behave differently from human tumors. Our previous findings have shown that subcutaneously implanted lung tumors exhibit more hypoxia than their orthotopic implanted or spontaneous K-ras-induced counterparts. We hypothesize that differences in hypoxia are due to site-specific differences in vascularity and perfusion.
Procedures
To compare the presence and functionality of vessels in these tumor models, we studied vascular perfusion in vivo in real time.
Results
Orthotopically implanted and spontaneous K-ras-induced lung tumors showed elevated perfusion, demonstrating vasculature functionality. Little contrast agent uptake was observed within the subcutaneously implanted tumors, indicating vascular dysfunction. These findings were corroborated at the microscopic level with Hoechst 33342 and Meca-32 staining.
Conclusions
From these observations, we concluded that differences in hypoxia in experimental models is related to vessel perfusion. Thus, appropriate selection of preclinical lung tumor models is essential for the study of hypoxia, angiogenesis and therapies targeting these phenomena.
Similar content being viewed by others
References
Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307:58–62
McDonald DM, Foss AJ (2000) Endothelial cells of tumor vessels: abnormal but not absent. Cancer Metastasis Rev 19:109–120
Morikawa S, Baluk P, Kaidoh T et al (2002) Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 160:985–1000
Hashizume H, Baluk P, Morikawa S et al (2000) Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156:1363–1380
Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249–257
Lunt SJ, Kalliomaki TM, Brown A et al (2008) Interstitial fluid pressure, vascularity and metastasis in ectopic, orthotopic and spontaneous tumours. BMC Cancer 8:2
Moeller BJ, Richardson RA, Dewhirst MW (2007) Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev 26:241–248
Moding EJ, Kastan MB, Kirsch DG (2013) Strategies for optimizing the response of cancer and normal tissues to radiation. Nat Rev Drug Discov 12:526–542
Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843–845
Marti HJ, Bernaudin M, Bellail A et al (2000) Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 156:965–976
Moeller BJ, Cao Y, Vujaskovic Z et al (2004) The relationship between hypoxia and angiogenesis. Semin Radiat Oncol 14:215–221
Young SD, Marshall RS, Hill RP (1988) Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci U S A 85:9533–9537
Brown JM (1999) The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res 59:5863–5870
Killion JJ, Radinsky R, Fidler IJ (1998) Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev 17:279–284
Hobbs SK, Monsky WL, Yuan F et al (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A 95:4607–4612
Fukumura D, Yuan F, Monsky WL et al (1997) Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am J Pathol 151:679–688
Ho KS, Poon PC, Owen SC, Shoichet MS (2012) Blood vessel hyperpermeability and pathophysiology in human tumour xenograft models of breast cancer: a comparison of ectopic and orthotopic tumours. BMC Cancer 12:579
Waters DJ, Janovitz EB, Chan TC (1995) Spontaneous metastasis of PC-3 cells in athymic mice after implantation in orthotopic or ectopic microenvironments. Prostate 26:227–234
Glinskii AB, Smith BA, Jiang P et al (2003) Viable circulating metastatic cells produced in orthotopic but not ectopic prostate cancer models. Cancer Res 63:4239–4243
Graves EE, Vilalta M, Cecic IK et al (2010) Hypoxia in models of lung cancer: implications for targeted therapeutics. Clin Cancer Res 16:4843–4852
Maity A, Koumenis C (2010) Location, location, location-makes all the difference for hypoxia in lung tumors. Clin Cancer Res 16:4685–4687
McDonald DM, Baluk P (2002) Significance of blood vessel leakiness in cancer. Cancer Res 62:5381–5385
Jackson A, O’Connor JP, Parker GJ, Jayson GC (2007) Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging. Clin Cancer Res 13:3449–3459
Jackson EL, Willis N, Mercer K et al (2001) Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15:3243–3248
Maatta AM, Makinen K, Ketola A et al (2008) Replication competent Semliki Forest virus prolongs survival in experimental lung cancer. Int J Cancer 123:1704–1711
Graves EE, Quon A, Loo BW Jr (2007) RT_Image: an open-source tool for investigating PET in radiation oncology. Technol Cancer Res Treat 6:111–121
Tofts PS, Brix G, Buckley DL et al (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223–232
Nolan-Stevaux O, Truitt MC, Pahler JC et al (2010) Differential contribution to neuroendocrine tumorigenesis of parallel egfr signaling in cancer cells and pericytes. Genes Cancer 1:125–141
Jung J (2014) Human tumor xenograft models for preclinical assessment of anticancer drug development. Toxicol Res 30:1–5
Field SB, Needham S, Burney IA et al (1991) Differences in vascular response between primary and transplanted tumours. Br J Cancer 63:723–726
Kerbel RS (2000) Tumor angiogenesis: past, present and the near future. Carcinogenesis 21:505–515
Frese KK, Tuveson DA (2007) Maximizing mouse cancer models. Nat Rev Cancer 7:645–658
Singh M, Murriel CL, Johnson L (2012) Genetically engineered mouse models: closing the gap between preclinical data and trial outcomes. Cancer Res 72:2695–2700
Kerbel RS (2003) Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived-but they can be improved. Cancer Biol Ther 2:S134–S139
Dutt A, Wong KK (2006) Mouse models of lung cancer. Clin Cancer Res 12:4396s–4402s
Olive KP, Jacobetz MA, Davidson CJ et al (2009) Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324:1457–1461
Downey CM, Aghaei M, Schwendener RA, Jirik FR (2014) DMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2′3′-cGAMP, induces M2 macrophage repolarization. PLoS One 9:e99988
Cai KX, Tse LY, Leung C et al (2008) Suppression of lung tumor growth and metastasis in mice by adeno-associated virus-mediated expression of vasostatin. Clin Cancer Res 14:939–949
Benjamin LE, Golijanin D, Itin A et al (1999) Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 103:159–165
Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM (1988) Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 133:95–109
Dreher MR, Liu W, Michelich CR et al (2006) Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J Natl Cancer Inst 98:335–344
Shuhendler AJ, Prasad P, Cai P et al (2013) Matrigel alters the pathophysiology of orthotopic human breast adenocarcinoma xenografts with implications for nanomedicine evaluation. Nanomedicine 9:795–805
Chen B, Pogue BW, Zhou X et al (2005) Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model. Clin Cancer Res 11:720–727
Acknowledgments
We acknowledge Dr. Alejandro Sweet-Cordero for the donation of the spontaneous lung cancer mouse model and the assistance of Leanne Sayles with the mouse model. The funding for this study was provided by NCI R01 CA131199, NCI P01 CA067166, and Agència de Gestió d’Ajuts Universitaris i de Recerca, Generalitat de Catalunya.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All animal experiments were done according to a protocol approved by the Institutional Animal Care and Use Committee.
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Vilalta, M., Hughes, N.P., Von Eyben, R. et al. Patterns of Vasculature in Mouse Models of Lung Cancer Are Dependent on Location. Mol Imaging Biol 19, 215–224 (2017). https://doi.org/10.1007/s11307-016-1010-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-016-1010-5